Submission Number: 26625
Submission ID: 96621
Submission UUID: 5e3f3274-b92c-43ba-81dc-88648035e24f

Created: Mon, 06/24/2024 - 17:59
Completed: Mon, 06/24/2024 - 17:59
Changed: Tue, 06/25/2024 - 19:24

Remote IP address: (unknown)
Submitted by: jill.simonetti_1
Language: English

Is draft: No

Locked: Yes
Health Department
Regents of the University of Minnesota
198663
Congenital Cytomegalovirus screening using newborn dried blood spots
{Empty}
To provide lab services to address the clinical sensitivity of polymerase chain reaction (PCR) performed on the newborn dried blood spot (DBS) in the context of universal newborn screening. In addition, for positive results, amplification of DNA for cytomegalovirus (CMV) genotyping, using the glycoprotein B genotyping approach is needed. This will help evaluate the feasibility of using DBS for CMV screening vs. urine and saliva.
Project Duration
Thu, 04/21/2016 - 00:00
Sat, 12/31/2016 - 00:00
Tue, 04/20/2021 - 00:00
Yes
{Empty}
Contract Amounts
$125959
$1358067
$1484026
Yes
CDC Emerging Infectious Diseases Grant
Yes
Dr. Mark Schleiss has the only lab in the country with the method and expertise to conduct this study.
Jill Simonetti
jill.simonetti@state.mn.us
Contractor fulfilled the timeliness component of this study.
Contractor's work was of superior quality.
Contractor's cost was comparable to what the agency would expect for this type of study.
Overall performance was excellent.
Yes
None
5 - very satisfied